Merit Medical Systems Inc
$ 66.53
-0.54%
12 Jun - close price
- Market Cap 3,990,313,000 USD
- Current Price $ 66.53
- High / Low $ 67.36 / 66.01
- Stock P/E 28.83
- Book Value 27.27
- EPS 2.32
- Next Earning Report 2026-07-29
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.09 %
- 52 Week High 96.74
- 52 Week Low 59.74
About
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, intensive care, and endoscopy. The company is headquartered in South Jordan, Utah.
Analyst Target Price
$89.55
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-30 | 2026-02-24 | 2025-10-30 | 2025-07-30 | 2025-04-24 | 2025-02-25 | 2024-10-30 | 2024-08-01 | 2024-04-30 | 2024-02-28 | 2023-10-26 | 2023-07-25 |
| Reported EPS | 0.94 | 1.04 | 0.46 | 1.01 | 0.86 | 0.93 | 0.86 | 0.92 | 0.77 | 0.81 | 0.75 | 0.81 |
| Estimated EPS | 0.83 | 0.9498 | 0.47 | 0.85 | 0.75 | 0.83 | 0.8 | 0.87 | 0.72 | 0.77 | 0.65 | 0.76 |
| Surprise | 0.11 | 0.0902 | -0.01 | 0.16 | 0.11 | 0.1 | 0.06 | 0.05 | 0.05 | 0.04 | 0.1 | 0.05 |
| Surprise Percentage | 13.253% | 9.4967% | -2.1277% | 18.8235% | 14.6667% | 12.0482% | 7.5% | 5.7471% | 6.9444% | 5.1948% | 15.3846% | 6.5789% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-29 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.85 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MMSI
2026-06-11 09:40:54
MedtechWOMEN announced the theme for its MedtechVISION 2026 Annual Conference, "The Breakthrough Imperative: Winning in an Ever-Changing Landscape," which will address medtech disruption caused by capital, AI, and geopolitics. The event, limited to 280 attendees, will feature Dr. Bayo Curry-Winchell as an inspirational patient keynote and Martha Aronson, CEO of Merit Medical Systems, discussing leadership in global healthcare. MedtechWOMEN is also accepting nominations for the Ferolyn Powell Leadership Award, recognizing those who advance medtech leadership and patient-centered innovation.
2026-06-09 08:52:00
Merit Medical Systems, Inc. (MMSI) is positioned for growth due to its strong product portfolio and continued investment in research and development, despite challenges from tariffs and China's macro pressures. The company's therapeutic products are a key growth engine, boosted by acquisitions like View Point Medical which expanded its oncology platform. While facing tariff-related cost pressures and OEM segment weakness, its estimate revision trend for 2026 is positive.
2026-06-08 18:40:49
Merit Medical Systems' Chief Legal Officer, Brian G. Lloyd, reported a charitable gift of 2,000 common shares. No consideration was received for this transaction, which reduced his direct holdings. After the gift, Lloyd directly owns 60,132 common shares and indirectly holds 2,000 shares through a 401(k) plan, in addition to various non-qualified stock options.
2026-06-08 15:39:41
Merit Medical Systems, Inc. (MMSI) is positioned for growth due to its strong product portfolio, including therapeutic products and the acquisition of View Point Medical, which expands its oncology platform. The company's focus on product innovation, like the Resilience Through-the-Scope Esophageal Stent, also supports future growth. However, challenges such as tariffs, weakness in the OEM segment, China macro pressure, and competitive markets pose headwinds for MMSI.
2026-06-06 17:39:41
Merit Medical Systems (MMSI) is currently trading at an estimated 34.1% discount to its intrinsic value and 38.9% below analyst targets, suggesting a potential undervaluation despite a challenging year for its stock. The company's strong growth in cardiovascular and endoscopy, new product development, and recent acquisitions position it well for long-term revenue growth driven by increasing demand for medical procedures. However, its P/E ratio of 27.6x is higher than the industry average, raising questions about whether the market is being overly cautious or realistic about its future growth prospects.
2026-06-05 16:39:05
Merit Medical Systems Inc. (NASDAQ: MMSI) is showing a near-term weak sentiment that may lead to a resumption of long-term weakness after a neutral shift. An exceptional 35.0:1 risk-reward short setup is identified, targeting a 10.3% downside against a 0.3% risk. AI models have generated three distinct trading strategies for MMSI: a Position Trading Strategy, a Momentum Breakout Strategy, and a Risk Hedging Strategy, each tailored to different risk profiles.
